MCP-5 suppresses osteoclast differentiation through Ccr5 upregulation

© 2024 Wiley Periodicals LLC..

Human monocyte chemoattractant protein-1 (MCP-1) in mice has two orthologs, MCP-1 and MCP-5. MCP-1, which is highly expressed in osteoclasts rather than in osteoclast precursor cells, is an important factor in osteoclast differentiation. However, the roles of MCP-5 in osteoclasts are completely unknown. In this study, contrary to MCP-1, MCP-5 was downregulated during receptor activator of nuclear factor kappa B ligand (RANKL)-induced osteoclast differentiation and was considered an inhibitory factor in osteoclast differentiation. The inhibitory role of MCP-5 in osteoclast differentiation was closely related to the increase in Ccr5 expression and the inhibition of IκB degradation by RANKL. Transgenic mice expressing MCP-5 controlled by Mx-1 promoter exhibited an increased bone mass because of a decrease in osteoclasts. This result strongly supported that MCP-5 negatively regulated osteoclast differentiation. MCP-5 also prevented severe bone loss caused by RANKL.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:239

Enthalten in:

Journal of cellular physiology - 239(2024), 2 vom: 15. Feb., Seite e31171

Sprache:

Englisch

Beteiligte Personen:

Kim, Jung Ha [VerfasserIn]
Kim, Kabsun [VerfasserIn]
Kim, Inyoung [VerfasserIn]
Seong, Semun [VerfasserIn]
Koh, Jeong-Tae [VerfasserIn]
Kim, Nacksung [VerfasserIn]

Links:

Volltext

Themen:

CCR5 protein, mouse
Ccr5
JNK
Journal Article
MCP-5
Membrane Glycoproteins
Monocyte Chemoattractant Proteins
NF-κB
NF-kappa B
Osteoclast
RANK Ligand
Receptor Activator of Nuclear Factor-kappa B

Anmerkungen:

Date Completed 16.02.2024

Date Revised 16.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/jcp.31171

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367046520